Nelda J. Connors

October 17, 2026

Barclays Raises Zebra Technologies Price Target to $416. Barclays maintained an Overweight rating on Zebra Technologies while raising its price target to $416. This action comes as the stock has experienced a significant 71% rally over the past six months, driven largely by automation trends. With the company already trading near its 52-week high, analysts are now debating whether the current valuation leaves little room for error despite the clear recovery.

October 17, 2026

Carnival shares up 17% in a month amid new cruise itineraries. Carnival Corporation stock has surged 17% over the past month, drawing attention to whether this rally is sustainable. The news cycle highlights new offerings from its brands, including Holland America Line's Bar 1873 venue and Seabourn's 2029 voyages to Egypt and Northern Europe. These developments support the company's narrative of expanding its premium inventory, though the recent price jump has raised questions about valuation for new entrants.

October 17, 2026

Baker Hughes signs long-term energy infrastructure deals. Baker Hughes has signed long-term agreements for energy infrastructure, signaling continued demand for its services. This news arrives as U.S. oil drillers pause activity despite rising prices, with the basin rig count falling by two. The company’s recent contract wins provide a stable backdrop for its operations amid shifting industry trends.

October 17, 2026

Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.